Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS INC

Security class unavailable · CUSIP: 10501E102

Event date: 2015-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
800,000
Percent of class
5.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000042
Form type
SC 13G
Filer
BRAINSTORM CELL THERAPEUTICS INC.
CIK
CIK 1137883
Filed
Feb 02, 2015
Reporting period
Jan 08, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub